Detalles de la búsqueda
1.
Selection of a trioxaquine as an antimalarial drug candidate.
Proc Natl Acad Sci U S A
; 105(45): 17579-84, 2008 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-18987321
2.
Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.
Eur J Pharmacol
; 450(1): 77-83, 2002 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-12176112
3.
[Design and birth of drugs]. / Conceptions et naissances des médicaments.
Rev Prat
; 52(5): 482-5, 2002 Mar 01.
Artículo
en Francés
| MEDLINE | ID: mdl-11949498
4.
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.
Hepatology
; 46(1): 122-9, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17526015
5.
In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum.
Drug Metab Dispos
; 34(4): 667-82, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16415117
6.
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice.
Am J Physiol Regul Integr Comp Physiol
; 284(2): R345-53, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12399252
7.
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
Proc Natl Acad Sci U S A
; 99(9): 6370-5, 2002 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-11959912
8.
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders.
J Pharmacol Exp Ther
; 301(1): 333-45, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11907191
9.
Structure and stereochemistry of the active metabolite of clopidogrel.
Drug Metab Dispos
; 30(11): 1288-95, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12386137
10.
Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist.
Can J Physiol Pharmacol
; 80(5): 482-8, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12056557
11.
Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.
J Pharmacol Exp Ther
; 300(3): 1122-30, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11861823
12.
SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
J Pharmacol Exp Ther
; 303(3): 1171-9, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12438541
13.
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization.
J Pharmacol Exp Ther
; 301(1): 322-32, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11907190
14.
SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
J Pharmacol Exp Ther
; 309(1): 414-24, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-14722330
Resultados
1 -
14
de 14
1
Próxima >
>>